Nephrolithiasis in autosomal dominant polycystic kidney disease

Journal of Endourology

Volumn 24, Issue 10, 2010, Pages 1557-1561

  Mufti, Uwais B ^a   Nalagatla, Sarath K ^a  

^a HAIRMYRES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCHRANE LIBRARY; COMORBIDITY; EMBASE; EXTRACORPOREAL LITHOTRIPSY; HUMAN; KIDNEY CYST; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; NEPHROLITHIASIS; NONHUMAN; PERCUTANEOUS NEPHROLITHOTOMY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

HUMANS; NEPHROLITHIASIS; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 77958017296     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2010.0093     Document Type: Review

References (48)

1. Perrone RD. Extrarenal manifestations of ADPKD. Kidney Int 1997;51:2022-2036.
2. Reeders ST, Breuning MH, Corney G, et al. Two genetic markers closely linked to adult polycystic kidney disease on chromosome 16. Br Med J 1986;292:851-853.
3. Pieke SA, Kimberling WJ, Kenyon KG, et al. Genetic heterogenicity of polycystic kidney disease: An estimate of the proportion of families unlinked to chromosome 16. Am J Hum Genet 1989;45:458.
4. Autosomal dominant polycystic kidney disease. In: Wein AJ, Kavoussi LR, Novick AS, Partin AW, Peters CA, eds. 9th ed. Campbell-Walsh Urology. Philadelphia: WB Saunders, 2007, pp 3318-3326.
5. Bear JC, Parfrey PS, Morgan JM, et al. Autosomal dominant polycystic kidney disease: New information for genetic counselling. Am J Med Genet 1992;43:548-553.
6. Yamaguchi T, Wallace DP, Magenheimer BS, et al. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growthstimulated phenotype. J Biol Chem 2004;279:40419-40430.
7. Shillingford JM, Murcia NS, Larson CH, et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 2006;103:5466-5471.
8. Ravine D, Gibson RN, Walker RG, et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease. Lancet 1994;343:824-827.
9. Nascimento AB, Mitchell DG, Zhang XM, et al. Rapid MR Imaging detection of renal cysts: Age-based standards. Radiology 2001;221:628-632.
10. Delaney VB, Adler S, Bruns FJ, et al. Autosomal dominant polycystic kidney disease: Presentation, complications, and prognosis. Am J Kidney Dis 1985;5:104-111.
11. Torres VE, Erickson SB, Smith LH, et al. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 1988;11:318-325.
12. Dimitrakov D, Simeonov S. Studies on nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Folia Med 1994;36:27-30.
13. Levine E, Grantham JJ. Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: Clinical and CT study in 84 patients. AJR Am J Roentgenol 1992;159:77-81.
14. Amar AD, Das S, Egan RM. Management of urinary calculous disease in patients with renal cysts: Review of 12 years of experience in 18 patients. J Urol 1981;125:153-156.
15. Grampsas SA, Chandhoke PS, Fan J, et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2000;36:53-57.
16. Torres VE, Wilson DM, Hattery RR, Segura JW. Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993;22:513-519.
17. Daudon M, Cohen-Solal F, Lacour B, Jungers P. Lithiases et anomalies des voies urinaires: La composition des calculs est-elle inde'pendante de l'anomalie anatomique? Prog Urol 2003;13:1320-1329.
18. Bisaz S, Felix R, Neuman WF, Fleisch H. Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Miner Electrolyte Metab 1978;1:74-83.
19. Fleisch H. Inhibitors and promoters of urinary stone formation. Kidney Int 1978;13:361-371.
20. Oreopoulos DG, Soyannwo MA, McGeown MG. Magnesium/calcium ratio in urine of patients with renal stones. Lancet 1968;2:420-422.
21. Trinchieri A, Mandressi A, Luongo P, et al. Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones. Scand J Urol Nephrol 1992;26:379-386.
22. Nishiura JL, Neves RF, Eloi SR, et al. Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 2009;4:838-844.
23. Kaehny WD, Tangel DJ, Johnson AM, et al. Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates. Am J Med 1990;89:49-52.
24. Wilson WT, Preminger GM. Extracorporeal shock wave lithotripsy: An update. Urol Clin North Am 1990;17:231-242.
25. Delakas D, Daskalopoulos G, Cranidis A. Extracorporeal shockwave lithotripsy for urinary calculi in autosomal dominant polycystic kidney disease. J Endourol 1997;11:167-170.
26. Al-Tawheed AR, Al-Awadi KA, Kehinde EO, et al. Treatment of calculi in kidneys with congenital anomalies: An assessment of the efficacy of lithotripsy. Urol Res 2006;34:291-298.
27. Chen WC, Lee YH, Huang JK, et al. Experience using extracorporeal shock-wave lithotripsy to treat urinary calculi in problem kidneys. Urol Int 1993;51:32-38.
28. Frick J, Sarica K, Köhle R, Kunit G. Long-term follow-up after extracorporeal shock wave lithotripsy in children. Eur Urol 1991;19:225-229.
29. Martinez Sarmiento M, Broseta Rico E, Sanz Chinesta S, et al. [Extracorporeal shock-wave lithotripsy in polycystic kidneys.] (Spa) Actas Urol Esp 1994;18:35-38.
30. Cass AS. Extracorporeal shock wave lithotripsy for renal stones with renal cysts present. J Urol 1995;153:599-601.
31. Deliveliotis C, Argiropoulos V, Varkarakis J, et al. Extracorporeal shock wave lithotripsy produces a lower stonefree rate in patients with stones and renal cysts. Int J Urol 2002;9:11-14.
32. Jaeger P, Redha S, Alund G, Uhlschmid G. [Do shock waves damage the kidney? Morphologic and functional changes of the kidney following exposure to shock waves.] (Ger) Schweiz Med Wochenschr 1989;119:944-949.
33. Jaeger P, Redha F, Marquardt K, et al. Morphological and functional changes in canine kidneys following extracorporeal shock-wave treatment. Urol Int 1995;54:48-58.
34. Evan AP, Willis LR, Connors B, et al. ESWL induces dose dependent changes in renal structure and function in the young mini pig. J Urol 1990;142:232. Abstract 173.
35. Karlsen SJ, Smevik B, Stenstrom J, Berg KJ. Acute physiological changes in canine kidneys following exposure to extracorporeal shock waves. J Urol 1990;143:1280-1283.
36. Chaussy CG, Fuchs GJ. Current state and future developments of noninvasive treatment of human urinary stones with extracorporeal shock wave lithotripsy. J Urol 1989;141:782-789.
37. Rutz-Danielczak A, Pupek-Musialik D, Raszeja-Wanic B. Effects of extracorporeal shock wave lithotripsy on renal function in patients with kidney stone disease. Nephron 1998;79:162-166.
38. Cass AS. Renal function after extracorporeal shock wave lithotripsy to a solitary kidney. J Endourol 1994;8:15-19.
39. Chandhoke PS, Albala DM, Clayman RV. Long-term comparison of renal function in patients with solitary kidneys and/or moderate renal insufficiency undergoing ESWL or percutaneous nephrolithotomy. J Urol 1991;145:323A.
40. Ng CS, Yost A, Streem SB. Nephrolithiasis associated with autosomal dominant polycystic kidney disease: Contemporary urological management. J Urol 2000;163:726-729.
41. Umbreit EC, Childs MA, Patterson DE, et al. Percutaneous nephrolithotomy for large or multiple upper tract calculi and autosomal dominant polycystic kidney disease. J Urol 2010;183:183-187.
42. Al-Kandari AM, Shoma AM, Eraky I, et al. Percutaneous nephrolithotomy for management of upper urinary tract calculi in patients with autosomal dominant polycystic kidney disease. Urology 2009;74:273-277.
43. Handa RK, Johnson CD, Connors BA, et al. Renal functional effects of simultaneous bilateral single-tract percutaneous access in pigs. BJU Int 2010;105:125-128.
44. Moskovitz B, Halachmi S, Sopov V, et al. Effect of percutaneous nephrolithotripsy on renal function: Assessment with quantitative SPECT of (99m) Tc-DMSA renal scintigraphy. J Endourol 2006;20:102-106.
45. Hegarty NJ, Desai MM. Percutaneous nephrolithotomy requiring multiple tracts: Comparison of morbidity with single-tract procedures. J Endourol 2006;20:753-760.
46. Kourambas J, Delvecchio FC, Munver R, Preminger GM. Nitinol stone retrieval-assisted ureteroscopic management of lower pole renal calculi. Urology 2000;56:935-939.
47. Kuo RL, Lingeman JE, Leveillee RJ, et al. Lower pole II: Initial results from a comparison of shock wave lithotripsy (SWL), ureteroscopy (URS), and percutaneous nephrostolithotomy (PNL) for lower pole nephrolithiasis. J Urol 2003;169:486.
48. Gambaro G, Fabris A, Puliatta D, Lupo A. Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 2006;34:102-107.